| Line Item | 2024-06-28 | Y/Y |
|---|---|---|
| Revenue | $6.55B | -11.3% |
| Cost of Revenue | $5.01B | -16.9% |
| R&D Expense | $654.0M | -17.9% |
| SG&A Expense | $460.0M | -6.3% |
| Operating Income | $452.0M | +232.2% |
| Interest Expense | $332.0M | +6.1% |
| Pre-tax Income | $445.0M | +189.7% |
| Income Tax | $110.0M | +233.3% |
| Net Income | $335.0M |
| Line Item | 2024-06-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.36B | +72.8% |
| Accounts Receivable | $429.0M | -30.9% |
| Inventory | $1.24B | +8.7% |
| Current Assets | $3.33B | +14.7% |
| Total Assets | $7.74B | +2.4% |
| Current Liabilities | $3.10B | +19.6% |
| Long-term Debt | $5.20B | -3.6% |
| Line Item | 2024-06-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $918.0M | -2.5% |
| Capital Expenditures | $254.0M | -19.6% |
| Investing Cash Flow | $126.0M | -41.9% |
| Financing Cash Flow | -$473.0M | +52.1% |
| Free Cash Flow | $664.0M | +6.1% |
| +163.3% |
| EPS (Basic) | $1.60 | +162.5% |
| EPS (Diluted) | $1.58 | +161.7% |
| Total Liabilities |
| $9.23B |
| +5.4% |
| Stockholders' Equity | -$1.49B | -24.4% |